Device
Transcutaneous stimulation
Transcutaneous stimulation is a medical device with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed133%
recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
recruitingnot_applicable
Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury
NCT07210411
recruitingnot_applicable
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
NCT06918119
completednot_applicable
Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement.
NCT02377765
Clinical Trials (3)
Showing 3 of 3 trials
NCT07210411Not Applicable
Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury
NCT06918119Not Applicable
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
NCT02377765Not Applicable
Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement.
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3